PLP.L - Polypipe Group plc

LSE - LSE Delayed price. Currency in GBp
438.20
+5.40 (+1.25%)
As of 2:22PM BST. Market open.
Stock chart is not supported by your current browser
Previous close432.80
Open437.00
Bid438.20 x N/A
Ask438.80 x N/A
Day's range433.80 - 441.20
52-week range305.40 - 451.80
Volume59,350
Avg. volume331,844
Market cap872.772M
Beta (3Y monthly)0.56
PE ratio (TTM)17.96
EPS (TTM)24.40
Earnings dateN/A
Forward dividend & yield0.12 (2.64%)
Ex-dividend date2019-04-18
1y target est459.00
  • Does This Valuation Of Polypipe Group plc (LON:PLP) Imply Investors Are Overpaying?
    Simply Wall St.6 days ago

    Does This Valuation Of Polypipe Group plc (LON:PLP) Imply Investors Are Overpaying?

    Today we will run through one way of estimating the intrinsic value of Polypipe Group plc (LON:PLP) by taking the...

  • Is Polypipe Group plc (LON:PLP) A Smart Pick For Income Investors?
    Simply Wall St.21 days ago

    Is Polypipe Group plc (LON:PLP) A Smart Pick For Income Investors?

    Could Polypipe Group plc (LON:PLP) be an attractive dividend share to own for the long haul? Investors are often drawn...

  • Here's Why I Think Polypipe Group (LON:PLP) Might Deserve Your Attention Today
    Simply Wall St.last month

    Here's Why I Think Polypipe Group (LON:PLP) Might Deserve Your Attention Today

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift...

  • What Does Polypipe Group plc's (LON:PLP) P/E Ratio Tell You?
    Simply Wall St.2 months ago

    What Does Polypipe Group plc's (LON:PLP) P/E Ratio Tell You?

    This article is for investors who would like to improve their understanding of price to earnings ratios (P/E ratios). We'll look at Polypipe Group plc's (LON:PLP) P/E ratio and reflect on what it tells us about the company's share...

  • EQS Group2 months ago

    Edison Investment Research Limited: Edison issues outlook on China Water Affairs Group (855)

    Edison Investment Research Limited 16-Apr-2019 / 10:03 GMT/BST * * *London, UK, 16 April 2019Edison issues outlook on China Water Affairs Group (855)We believe China Water Affairs Group's (CWA) strong financial position (net debt/equity FY18 c 70%) and impressive track record of generating returns for shareholders should enable it to exploit the favourable market conditions and allow for a continuation of its strong growth profile. Following the recent acquisition of 29.5% of Kangda International, CWA's market valuation appears undemanding compared to its peers despite its track record of delivering attractive returns for its shareholders.Applying peer group average multiples would indicate a valuation of c HK$11.4 per share (up HK$0.9 per share since we last published in December 2018), for CWA, c HK$3 per share above the current share price. At HK$8.2 per share, CWA trades on a PEG ratio of only 0.6x versus 1.6x for its peers. Applying an undemanding PEG ratio of 1.0x would indicate a valuation of HK$13.0 per share. Our DCF points to a valuation of HK$11.9 per share. Click here to view the full report.All reports published by Edison are available to download free of charge from its website www.edisongroup.comAbout Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.Edison is authorised and regulated by the Financial Conduct Authority.Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.For more information please contact Edison:Graeme Moyse, +44 (0)20 3077 5700 Industrials@edisongroup.comLearn more at www.edisongroup.com and connect with Edison on: LinkedIn https://www.linkedin.com/company/edison-investment-research Twitter www.twitter.com/Edison_Inv_Res YouTube www.youtube.com/edisonitv * * *Dissemination of a CORPORATE NEWS, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. * * * End of Announcement - EQS News Service

  • EQS Group2 months ago

    Edison issues outlook on Primary Health Properties (PHP)

    Edison Investment Research Limited 10-Apr-2019 / 13:28 GMT/BST * * *London, UK, 10 April 2019Edison issues outlook on Primary Health Properties (PHP)Primary Health Properties' (PHP's) all-share merger with MedicX completed as planned on 14 March 2019, creating the leading primary healthcare investor in the UK and the Republic of Ireland. Our earnings forecasts immediately benefit from cost efficiencies, while the combination of two high-quality portfolios creates a scale platform, well placed to profitably address the substantial investment needs of the primary healthcare sectors in both countries.PHP offers an attractive and growing dividend, fully covered by earnings. Income visibility is strong, with revenues supported by secure, long-term income, substantially subject to upward-only review, with little exposure to the economic cycle, or fluctuations in occupancy. The complementary nature of the merger and added scale enhance future growth prospects. Click here to view the full report.All reports published by Edison are available to download free of charge from its website www.edisongroup.comAbout Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.Edison is authorised and regulated by the Financial Conduct Authority.Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.For more information please contact Edison:Martyn King, +44 (0)20 3077 5745 Andrew Mitchell, +44 (0)20 3681 2500 financials@edisongroup.comLearn more at www.edisongroup.com and connect with Edison on: LinkedIn https://www.linkedin.com/company/edison-investment-research Twitter www.twitter.com/Edison_Inv_Res YouTube www.youtube.com/edisonitv * * *Dissemination of a CORPORATE NEWS, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. * * * End of Announcement - EQS News Service

  • Does Polypipe Group plc's (LON:PLP) 8.4% Earnings Growth Reflect The Long-Term Trend?
    Simply Wall St.2 months ago

    Does Polypipe Group plc's (LON:PLP) 8.4% Earnings Growth Reflect The Long-Term Trend?

    Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! Assessing Polypipe Group plc's (LON:PLP) past track record of performance is an insightful exercise for investors. It allows...

  • EQS Group3 months ago

    Edison Investment Research Limited: Edison issues outlook on Telix Pharmaceuticals (TLX)

    Edison Investment Research Limited 03-Apr-2019 / 10:56 GMT/BST * * *London, UK, 3 April 2019Edison issues outlook on Telix Pharmaceuticals (TLX)Telix Pharmaceuticals has added significant value by acquiring ANMI, the developer of its TLX591-CDx prostate cancer imaging kit and underlying 'cold kit' technology. It also announced plans to accelerate its TLX591 prostate cancer therapeutic into Phase III, based on a third-party review of clinical data that formed part of the Atlab acquisition in September. Following the ANMI acquisition we increase our valuation to A$380m (vs A$303m) or A$1.74 per share (vs A$1.43 per share). FDA agreement to the TLX591 Phase III design would likely prompt a further valuation uplift.We lift our valuation to A$380m (vs A$303m) or A$1.74/share (vs A$1.43/share). We have revised our model for the ANMI acquisition and the resultant move to 100% of global rights to TLX591-CDx (vs the prior US-only JV). We assume ex-US sales will match our US peak sales forecast of US$80m and an operating profit margin (before royalties) of 35% in the US and 25% in other territories. We will review our valuation if Telix gains FDA agreement to progress TLX591 to Phase III. Click here to view the full report.All reports published by Edison are available to download free of charge from its website www.edisongroup.comAbout Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.Edison is authorised and regulated by the Financial Conduct Authority.Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.For more information please contact Edison:Dennis Hulme, +61 (0)2 8249 8345 John Savin, +44 (0)20 3077 5735 healthcare@edisongroup.com Learn more at www.edisongroup.com and connect with Edison on: LinkedIn https://www.linkedin.com/company/edison-investment-research Twitter www.twitter.com/Edison_Inv_Res YouTube www.youtube.com/edisonitv * * *Dissemination of a CORPORATE NEWS, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. * * * End of Announcement - EQS News Service

  • EQS Group3 months ago

    Edison Investment Research Limited: Edison issues outlook on Polypipe (PLP)

    Edison Investment Research Limited 02-Apr-2019 / 12:08 GMT/BST * * *London, UK, 2 April 2019Edison issues outlook on Polypipe (PLP)Polypipe's rating is currently slightly ahead of its sector, but this overlooks the company's positioning in long-term growth segments, in our view. The FY18 trading performance was noticeably stronger in H2, though margin progression was constrained by short-term production inefficiencies in certain areas. Management provide a clear and consistent message regarding business focus under a refreshed, growth-oriented strategy.After a weak close to 2018, Polypipe's share price has rebounded strongly (being up x15% ytd and also c 8% over the last 12 months) though is now off the 432.60p high seen just before the FY18 results announcement. We note that some but not all of the quoted UK housebuilders have also had a strong start to the year in share price terms and the long-term structural UK housing shortage theme is intact. Polypipe's modest P/E premium compared to UK listed peers does not reflect its leading market share positions and strategic positioning to develop further in our view. Click here to view the full report.Subscribe to Edison's content to receive reports by email. All reports published by Edison are free-to-access and available on the website.About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.Edison is authorised and regulated by the Financial Conduct Authority.Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.For more information please contact Edison:Toby Thorrington, +44 (0)20 3077 5721industrials@edisongroup.com Learn more at www.edisongroup.com and connect with Edison on: LinkedIn https://www.linkedin.com/company/edison-investment-research Twitter www.twitter.com/Edison_Inv_Res YouTube www.youtube.com/edisonitv * * *Dissemination of a CORPORATE NEWS, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. * * * End of Announcement - EQS News Service

  • Polypipe Group plc (LON:PLP) Earns Among The Best Returns In Its Industry
    Simply Wall St.4 months ago

    Polypipe Group plc (LON:PLP) Earns Among The Best Returns In Its Industry

    Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize! Today we are going to look at Polypipe Group plcRead More...

  • Did Polypipe Group plc (LON:PLP) Insiders Buy Up More Shares?
    Simply Wall St.5 months ago

    Did Polypipe Group plc (LON:PLP) Insiders Buy Up More Shares?

    We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On the other hand, we'd be remiss not to mention Read More...

  • How Good Is Polypipe Group plc (LON:PLP), When It Comes To ROE?
    Simply Wall St.6 months ago

    How Good Is Polypipe Group plc (LON:PLP), When It Comes To ROE?

    One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return Read More...

  • Simply Wall St.6 months ago

    Polypipe Group plc’s (LON:PLP) Most Important Factor To Consider

    If you are currently a shareholder in Polypipe Group plc (LON:PLP), or considering investing in the stock, you need to examine how the business generates cash, and how it is Read More...

  • What You Must Know About Polypipe Group plc’s (LON:PLP) Financial Strength
    Simply Wall St.7 months ago

    What You Must Know About Polypipe Group plc’s (LON:PLP) Financial Strength

    Investors are always looking for growth in small-cap stocks like Polypipe Group plc (LON:PLP), with a market cap of UK£774m. However, an important fact which most ignore is: how financially Read More...

  • Simply Wall St.8 months ago

    What To Know Before Buying Polypipe Group plc (LON:PLP) For Its Dividend

    Dividends can be underrated but they form a large part of investment returns, playing an important role in compounding returns in the long run. In the last few years Polypipe Read More...

  • Simply Wall St.8 months ago

    Polypipe Group plc (LON:PLP) Is Trading At A 41.2% Discount

    In this article I am going to calculate the intrinsic value of Polypipe Group plc (LON:PLP) by taking the foreast future cash flows of the company and discounting them back Read More...

  • Is Polypipe Group plc (LON:PLP) Attractive At This PE Ratio?
    Simply Wall St.9 months ago

    Is Polypipe Group plc (LON:PLP) Attractive At This PE Ratio?

    This analysis is intended to introduce important early concepts to people who are starting to invest and want to learn about the link between company’s fundamentals and stock market performance.Read More...

  • Only 2 Days Left To Polypipe Group plc (LON:PLP)’s Ex-Dividend Date, Is It Worth Buying?
    Simply Wall St.10 months ago

    Only 2 Days Left To Polypipe Group plc (LON:PLP)’s Ex-Dividend Date, Is It Worth Buying?

    Important news for shareholders and potential investors in Polypipe Group plc (LON:PLP): The dividend payment of UK£0.037 per share will be distributed into shareholder on 21 September 2018, and theRead More...

  • What Do Analysts Think About The Future Of Polypipe Group plc’s (LON:PLP)?
    Simply Wall St.10 months ago

    What Do Analysts Think About The Future Of Polypipe Group plc’s (LON:PLP)?

    Since Polypipe Group plc (LON:PLP) released its earnings in June 2018, it seems that analyst forecasts are fairly optimistic, as a 27.87% increase in profits is expected in the upcomingRead More...

  • Are Insiders Too Confident In Polypipe Group plc (LON:PLP)?
    Simply Wall St.last year

    Are Insiders Too Confident In Polypipe Group plc (LON:PLP)?

    Polypipe Group plc, through its subsidiaries, designs, develops, and manufactures plastic piping systems, water management solutions, and ventilation systems in the United Kingdom, other European countries, and internationally. Polypipe Group’sRead More...

By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes